|
Spearman correlation coefficients comparing mean changes on the ADAS-Cog, CIBIC-Plus, PGAS and CGAS with mean changes on other outcomes at 6 months |
|||||||
| ADAS-Cog |
ADAS-Cog |
ADAS-Cog |
|||||
| improved |
no change |
worsened |
ADAS-Cog |
CIBIC-Plus |
PGAS* |
CGAS* |
|
| (n = 19) |
(n = 53) |
(n = 23) |
(n = 95) |
(n = 95) |
(n = 95) |
(n = 95) |
|
|
|
|||||||
| CIBIC-Plus |
-0.15 |
0.15 |
0.38 |
0.27 |
1.00 |
||
| PGAS* |
0.40 |
-0.32 |
-0.15 |
-0.09 |
-0.59 |
1.00 |
|
| Cognition* |
0.58 |
-0.50 |
-0.32 |
-0.22 |
-0.60 |
0.81 |
0.58 |
| Function* |
0.23 |
-0.25 |
-0.07 |
-0.03 |
-0.27 |
0.69 |
0.22 |
| Behaviour* |
-0.33 |
0.17 |
-0.17 |
-0.06 |
-0.12 |
0.47 |
0.18 |
| Leisure* |
0.44 |
-0.32 |
-0.15 |
-0.11 |
-0.50 |
0.87 |
0.36 |
| Social* |
0.73 |
-0.32 |
-0.50 |
-0.04 |
-0.52 |
0.72 |
0.39 |
| CGAS* |
0.33 |
-0.09 |
-0.32 |
-0.22 |
-0.77 |
0.52 |
1.00 |
| Cognition* |
0.41 |
-0.12 |
-0.27 |
-0.21 |
-0.69 |
0.51 |
0.84 |
| Function* |
0.36 |
-0.29 |
0.20 |
-0.14 |
-0.60 |
0.51 |
0.77 |
| Behaviour* |
0.20 |
0.35 |
-0.43 |
-0.30 |
-0.72 |
0.41 |
0.89 |
| Leisure* |
-1.00 |
0.11 |
0.29 |
0.12 |
-0.25 |
0.32 |
0.63 |
| Social* |
0.15 |
-0.31 |
0.21 |
0.01 |
-0.76 |
0.48 |
0.86 |
| MMSE* |
0.59 |
-0.18 |
-0.24 |
-0.35 |
-0.29 |
0.24 |
0.32 |
| PSMS |
-0.28 |
0.00 |
0.37 |
0.21 |
0.51 |
-0.36 |
-0.53 |
| IADL |
-0.29 |
0.16 |
-0.15 |
0.11 |
0.37 |
-0.27 |
-0.46 |
| CSD |
0.24 |
-0.03 |
0.39 |
0.25 |
0.40 |
-0.15 |
-0.53 |
|
*Higher scores indicate better performance (the expected direction is positive), otherwise lower scores indicate improvement. | |||||||
Rockwood et al. BMC Neurology 2007 7:26 doi:10.1186/1471-2377-7-26 |
|||||||